▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1224 by analyst upside · 2026-09-09
MDXG
MiMedx Group, Inc.
Healthcare · Market Cap $682M · P/E 116.8x
ANALYST PRICE TARGET
+58.5%
implied upside to consensus target
Current Price $4.67
Consensus Target $7.4
Bull Target $8.0
Bear Target $6.0
Analysts Covering 5
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
4
Hold
0
Sell
0
52-Week Low $3.03
52-Week High $7.97
YTD Return -27.9%
FUNDAMENTALS
Market Cap $682M
P/E Ratio (TTM) 116.8x
Forward P/E 23.3x
EPS (TTM) $0.04
PEG Ratio 2.88
Dividend Yield N/A
Revenue (TTM) $355M
Profit Margin 1.8%
52-WEEK RANGE
52-Week Low $3.03
52-Week High $7.97
Current Price $4.67
Bear Target $6.0
Bull Target $8.0
● Now $4.67 ● Target $7.4
TRADING DATA
Avg Volume 1.3M
YTD Return -27.9%
Analyst Count 5
Consensus Buy
Upside to Target +58.5%
Last Updated 2026-09-09

ANALYST SUMMARY

MiMedx Group, Inc. (MDXG) is currently trading at $4.67 with a Wall Street consensus price target of $7.4, implying potential upside of 58.5% over the next 12 months. 5 analysts currently cover MDXG, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $8.0, while the most cautious has a target of $6.0.

MDXG operates in the Healthcare sector with a market capitalisation of $682M. The stock is down 27.9% year-to-date and is currently trading near the lower end of its 52-week range of $3.03 – $7.97.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

NRC +22.7%
NRC Health
$469M · P/E 88.3x · Strong Buy
HSTM +20.1%
HealthStream, Inc.
$840M · P/E 39.9x · Buy
PNTG +18.7%
The Pennant Group, Inc.
$1B · P/E 43.2x · Buy
VREX +2.2%
Varex Imaging Corporation
$779M · P/E 34.9x · Hold
KMDA +62.8%
Kamada Ltd.
$478M · P/E 21.8x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for MDXG, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Craig-Hallum - Reiterated
Buy → Buy 2026-08-27 Building track record
Cantor Fitzgerald reit
Overweight → Overweight 2026-08-17 40% win rate (10 calls)
Citizens - Reiterated
Market Outperform → Market Outperform 2026-04-30 Building track record
Citizens - Reiterated
Market Outperform → Market Outperform 2026-04-20 Building track record
Craig-Hallum - Reiterated
Buy → Buy 2026-04-17 Building track record
Citizens ● Initiated
Market Outperform 2026-02-23 Building track record
Cantor Fitzgerald - Reiterated
Overweight → Overweight 2026-02-17 40% win rate (10 calls)
Lake Street - Reiterated
Buy → Buy 2026-01-20 27% win rate (11 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
62
out of 100
Coverage depth
14/30
Consensus clarity
21/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →